查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1852786

復苏设备市场（按设备类型、应用程式、最终用户和销售管道）——全球预测，2025-2032年

Resuscitation Devices Market by Device Type, Application, End User, Sales Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，復苏设备市场规模将达到 116.9 亿美元，复合年增长率为 5.59%。

关键市场统计数据
基准年 2024 75.6亿美元
预计年份：2025年 79.8亿美元
预测年份 2032 116.9亿美元
复合年增长率 (%) 5.59%

简明扼要地阐述了技术、临床需求和商业化这三者之间的策略交汇点，以此定义现代復苏的优先事项。

本执行摘要概述了影响技术创新、应用和采购的策略因素。科技的快速发展、对院外照护日益增长的关注，以及在临床和家庭环境中不断扩展的应用场景，都提升了去心房颤动、植入式装置和穿戴式疗法的知名度和战略重要性。在此背景下，从产品开发到医院采购的相关人员必须兼顾临床疗效、监管路径、报销复杂性和分销动态，才能保持竞争力。

这一领域的特征是产品迭代速度加快、与数位健康平台紧密整合，以及更重视以使用者为中心的设计，以支援非临床急救人员。同时，与电子健康记录和远端检测系统的互通性正逐渐成为一项基本要求，而非差异化优势。在此背景下，决策者必须明确临床需求、监管限制和商业机会的交会点。本导言概述了新兴趋势、关税相关影响、市场区隔洞察、区域发展、竞争动态和建议措施，为后续章节奠定了基础，并为復苏医疗设备领域的领导者提供了一套实用的行动指南。

小型化、互联互通和不断变化的医疗环境的融合如何重新定义復苏设备的产品设计重点和竞争优势？

復苏设备领域正经历变革时期的驱动力来自于技术创新、医疗环境的扩展以及临床通讯协定的演变。首先，小型化和更高的能源效率使得更便携、更易于使用的外部设备成为可能。同时，导线设计和电池化学的创新延长了植入式系统的使用寿命并提高了其可靠性。此外，心律不整检测和自适应起搏逻辑的演算法进步提高了临床诊断的准确性，减少了不必要的干预，并增强了患者的安全性。

其次，医疗服务范围从三级医院扩展到门诊中心、居家照护机构和社区公共场所，再形成了产品需求。復苏解决方案如今必须在临床级性能、易用性、远端监控功能和经济高效的维护之间取得平衡。云端事件报告、远距离诊断和装置管理平台对于生命週期支援和上市后监管至关重要。最后，监管机构日益关注网路安全、软体检验和实际效能数据，这些都需要工程、临床和监管团队之间的跨职能协作。因此，能够整合临床证据产生、数位化服务和灵活上市模式的公司将获得永续的竞争优势。

受关税干预措施的影响，策略供应链重组和采购策略调整正在改变，这些措施重塑了成本结构和筹资策略。

美国关税于2025年实施，由此引发了一系列成本和供应链动态动态，要求製造商、经销商和医疗系统进行策略调整。关税导致投入成本上升，使得筹资策略受到更严格的审查，促使各机构重新评估供应商关係、近岸外包方案以及在控製成本的同时维持临床性能的组件级替代方案。为此，一些製造商加快了对替代供应商的资格认证，优先考虑可实现在地采购的模组化设计，并加强了谈判，最终达成了更长期的采购协议和供应保证。

除了对成本的直接影响外，关税还影响了库存计划和前置作业时间管理，迫使采购团队采用更复杂的需求预测技术和安全库存策略。这种转变促使销售和营运团队加强协作，以使合约条款与生产实际情况相符，并在可能的情况下实施更灵活的生产能力。此外，关税也使捆绑式维护、延长保固和远端监控等附加价值服务更具吸引力，从而抵消了价格敏感度并维持了净利率。展望未来，建立具有弹性的供应链和透明的成本沟通对于维持市场进入和支持长期临床应用至关重要。

全面的細項分析揭示了产品类型、临床用途、终端用户环境和销售管道如何影响产品策略和商业性执行。

了解市场区隔的细微差别，有助于我们了解每种设备类型、临床应用、最终用户和销售管道的独特发展路径和商业化策略。按装置类型划分，竞争格局包括自动体外心臟去颤去心房颤动 ( AED)、植入式心臟整流去颤器) 、手动体外去心房颤动去心房颤动) 和可穿戴式去心房颤动。在这一格局中，AED 又可细分为全自动和半自动； 植入式心臟整流去颤器包括双心室、双侧心室和单心室； 去心房颤动则分为携带式和固定式。这些差异会影响产品设计重点、监管证据需求和上市后支援模式，其中植入式技术需要长期临床数据，而体外设备则更注重易用性和维护性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧驱动的预测分析技术整合到自动体外去颤器（AED）中，以便在心臟病发作前进行检测。
  • 携带式体外膜氧合技术在现场復苏支持的进展
  • 在紧急情况下，无需电池的动能术辅助设备的使用率正在上升。
  • 云端连接去心房颤动集群的出现，实现了集中式性能分析​​和维护警报
  • 将即时远端医疗连接整合到自动化復苏单元中，以支援远距临床教学

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依设备类型分類的復苏设备市场

  • 自动体外心臟去心房颤动
    • 全自动
    • 半自动
  • 植入式心臟整流去颤器
    • 双心室
    • 两个腔室
    • 单腔
  • 手动体外去心房颤动
    • 可携式的
    • 固定式
  • 去心房颤动

第九章 按应用分類的復苏设备市场

  • 心臟麻痹
    • 心臟起搏
    • 心臟復律
    • 去心房颤动
  • 呼吸衰竭
    • 侵入性通气
    • 人工復苏
    • 非侵入性通气

第十章 按最终用户分類的復苏设备市场

  • 门诊治疗中心
  • 紧急医疗服务
  • 居家照护
  • 医院
  • 专科诊所

第十一章 復苏设备市场（依销售管道划分）

  • 直销
  • 经销商
  • 线上销售

第十二章 各地区復苏设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 按组别分類的復苏设备市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国復苏设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Koninklijke Philips NV
    • Medtronic plc
    • ZOLL Medical Corporation
    • Nihon Kohden Corporation
    • Dragerwerk AG & Co. KGaA
    • Ambu A/S
    • Becton, Dickinson and Company
    • Teleflex Incorporated
    • Smiths Group plc
    • Mindray Medical International Limited
Product Code: MRR-3D2FD205BF84

The Resuscitation Devices Market is projected to grow by USD 11.69 billion at a CAGR of 5.59% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.56 billion
Estimated Year [2025] USD 7.98 billion
Forecast Year [2032] USD 11.69 billion
CAGR (%) 5.59%

A concise orientation to the strategic intersection of technology, clinical demand, and commercialization that defines modern resuscitation device priorities

Resuscitation devices occupy an essential intersection of emergency medicine, cardiac care and respiratory support, and this executive summary synthesizes the strategic factors shaping innovation, adoption, and procurement. Rapid technological advances, heightened focus on out-of-hospital care, and expanding use cases in both clinical and home environments have elevated the visibility and strategic importance of defibrillators, implantable devices, and wearable therapies. Against this backdrop, stakeholders from product development to hospital procurement must reconcile clinical efficacy, regulatory pathways, reimbursement complexity, and distribution dynamics to remain competitive.

The landscape is characterized by accelerated product iterations, tighter integration with digital health platforms, and increasing emphasis on user-centered design that supports non-clinical responders. Meanwhile, interoperability with electronic health records and telemetry systems is becoming a de facto expectation rather than a differentiator. In this context, decision-makers need clarity on where clinical needs, regulatory constraints, and commercial opportunity converge. This introduction frames the subsequent sections by outlining the emergent trends, tariff-related impacts, segmentation insights, regional dynamics, competitor movements, and recommended actions that together form a practical playbook for leaders in the resuscitation device domain.

How converging advances in miniaturization, connectivity, and care setting shifts are redefining product design priorities and competitive advantage for resuscitation devices

The resuscitation device landscape is undergoing transformative shifts driven by technological innovation, expanded care settings, and evolving clinical protocols. First, miniaturization and power-efficiency gains have enabled more portable and user-friendly external devices while innovations in lead design and battery chemistry are extending the longevity and reliability of implantable systems. Concurrently, algorithmic advances in arrhythmia detection and adaptive pacing logic have improved clinical accuracy, reducing unnecessary interventions and enhancing patient safety.

Second, the expansion of care beyond tertiary hospitals into ambulatory care centers, homecare settings and community public spaces has reshaped product requirements. Resuscitation solutions must now balance clinical-grade performance with simplicity of operation, remote monitoring capability, and cost-effective maintenance. Third, software and connectivity have become central to device value propositions; cloud-enabled event reporting, remote diagnostics and device management platforms are integral to lifecycle support and post-market surveillance. Finally, regulatory agencies are increasingly focused on cybersecurity, software validation, and real-world performance data, which together demand cross-functional alignment between engineering, clinical, and regulatory teams. As a result, companies that integrate clinical evidence generation, digital services and flexible go-to-market models will gain sustainable competitive advantages.

Strategic supply chain reconfiguration and procurement adaptations prompted by tariff interventions that reshaped cost structures and sourcing strategies

The implementation of United States tariffs in 2025 introduced a set of cost and supply-chain dynamics that require strategic recalibration for manufacturers, distributors and health systems. Tariff-induced input cost increases have intensified scrutiny of sourcing strategies, prompting organizations to re-evaluate supplier relationships, nearshoring options and component-level substitutions that preserve clinical performance while managing cost exposure. In response, some manufacturers accelerated qualification of alternate suppliers, prioritized modular designs that allow localized sourcing, and intensified negotiations tied to longer-term purchase agreements and supply guarantees.

Beyond direct cost impacts, tariffs affected inventory planning and lead-time management, pushing procurement teams to adopt more sophisticated demand-forecasting practices and safety-stock strategies. This shift led to increased collaboration between sales and operations teams to align contract terms with production realities and to introduce more flexible manufacturing capacity where feasible. Additionally, the tariffs heightened the appeal of value-added services-such as bundled maintenance, extended warranties, and remote monitoring-to offset price sensitivity and preserve margins. Moving forward, resilient supply-chain design and transparent cost communication will be critical for maintaining market access and supporting long-term clinical adoption.

Comprehensive segmentation analysis revealing how device type, clinical application, end-user setting, and sales channel collectively shape product strategies and commercial execution

A nuanced appreciation of market segmentation illuminates distinct development pathways and commercialization strategies across device types, clinical applications, end users and sales channels. Based on device type, the competitive arena encompasses Automated External Defibrillators, Implantable Cardioverter Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators; within that scope, Automated External Defibrillators are subdivided into Fully Automatic and Semi Automatic variants, Implantable Cardioverter Defibrillators include Biventricular, Dual Chamber and Single Chamber configurations, and Manual External Defibrillators appear in Portable and Stationary formats. These distinctions influence product design priorities, regulatory evidence needs, and post-market support models, with implantable technologies demanding long-term clinical data and external devices focusing on ease of use and maintenance.

Based on application, clinical use cases center on Cardiac Arrest and Respiratory Failure; Cardiac Arrest management includes modalities such as Cardiac Pacing, Cardioversion and Defibrillation, whereas Respiratory Failure care spans Invasive Ventilation, Manual Resuscitation and Non Invasive Ventilation. These application-based differences drive device feature sets, integration requirements with airway and monitoring equipment, and training protocols for end users. Based on end user, the landscape spans Ambulatory Care Centers, Emergency Medical Services, Homecare environments, Hospitals and Specialty Clinics, each of which has distinct procurement cycles, clinical competencies and service expectations. Finally, based on sales channel, market access is achieved through Direct Sales, Distributors and Online Sales strategies, each requiring tailored commercial approaches from field-based clinical engagement to digital marketing and logistics optimization. Understanding the interplay among these segmentation dimensions enables targeted product roadmaps, differentiated value propositions and channel-specific commercial tactics that resonate with clinical and operational buyers.

Regional decision drivers and market access dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence adoption and commercialization strategies

Regional dynamics exert a powerful influence on regulatory timelines, reimbursement mechanisms, and adoption velocities for resuscitation devices. In the Americas, healthcare systems demonstrate a heterogeneous mix of private and public procurement behaviors, where reimbursement clarity and emergency medical services integration are key determinants of adoption. Market participants must align clinical evidence generation and health economics messaging to the priorities of payers and hospital networks in order to drive procurement and deployment decisions.

In Europe, Middle East & Africa, regulatory harmonization efforts and regional procurement consortia create both opportunities and complexities; manufacturers need differentiated regulatory strategies that respect local conformity assessment processes and emerging digital health requirements. In many markets across this region, public tenders and centralized purchasing platforms make pricing transparency and long-term service commitments decisive factors in vendor selection. In the Asia-Pacific region, rapid infrastructure investments, growing chronic disease burdens and expanding primary care capacity accelerate demand for both acute and ambulatory resuscitation solutions. However, market entry often requires careful navigation of local distribution partnerships, product localization, and country-specific regulatory and reimbursement pathways. By aligning commercial models with regional decision drivers, companies can prioritize market entry sequencing and resource allocation to maximize impact.

An overview of competitor strategies, collaborative evidence generation, and capability acquisition trends that define competitive advantage in resuscitation technologies

Competitive dynamics in the resuscitation device space are characterized by a mix of established medical device manufacturers and emerging technology-focused entrants, each pursuing differentiated strategies across product innovation, clinical partnerships and service models. Incumbent manufacturers continue to invest in incremental improvements to implantable lead systems, energy delivery optimization and device longevity, leveraging robust clinical trial data and established distribution networks to defend market share. At the same time, newer entrants emphasize software-enabled diagnostics, machine-learning driven arrhythmia detection and cloud-based device management to create adjacent revenue streams and enhance post-market surveillance.

Collaborations between device developers and large health systems or emergency medical services organizations are increasingly common, enabling real-world evidence generation and accelerated product refinement. Moreover, strategic acquisitions and licensing arrangements remain key mechanisms for companies seeking rapid capability enhancement in digital health, battery technology or telemetry. Amid these trends, successful players demonstrate strong cross-functional coordination between R&D, clinical affairs and commercial teams to shorten feedback loops and ensure that product enhancements map directly to demonstrable clinical or operational benefits. The competitive landscape thus rewards organizations that can couple clinical credibility with agile product development and scalable service delivery.

Actionable commercial, regulatory, and operational priorities that industry leaders should implement to secure resilience, growth, and adoption in resuscitation device markets

Industry leaders should prioritize a set of practical actions to capitalize on demand shifts and technological advances while mitigating regulatory and supply-chain risks. First, align product roadmaps with clinical workflows by validating features through clinician advisory panels and pragmatic, real-world evaluations. This ensures that design choices address frontline usability and translate to measurable improvements in response times and patient outcomes. Second, invest in modular architectures and supplier diversification to reduce single-source dependency and enable rapid component substitution when supply chain disruptions occur. Third, develop integrated digital services that complement device sales, such as remote monitoring, training platforms and outcome analytics, which can strengthen customer retention and create recurring revenue.

Fourth, adopt flexible commercial models that combine direct field engagement for high-acuity settings with distributor partnerships and e-commerce strategies for broader reach and cost efficiency. Fifth, proactively engage regulatory authorities on software and cybersecurity expectations to preempt compliance bottlenecks and accelerate approvals. Finally, build cross-functional go-to-market playbooks that link clinical evidence generation, health economics messaging and procurement value propositions to reduce sales cycles and improve win rates. By implementing these actions in a coordinated manner, organizations can improve resilience, accelerate adoption and sustain profitable growth.

A transparent multi-method research approach combining clinician engagement, regulatory review, and cross-validated secondary analysis to support actionable strategic recommendations

This research synthesis is grounded in a multi-method approach that combines primary stakeholder engagement, secondary literature synthesis and systematic policy review to ensure robust, actionable insights. Primary inputs were gathered through structured interviews with clinicians, procurement decision-makers, and device engineers to capture frontline perspectives on device performance, usability challenges and procurement constraints. These qualitative engagements were complemented by targeted consultations with regulatory specialists to interpret evolving guidance on software, cybersecurity, and post-market surveillance requirements.

Secondary sources were analyzed to contextualize technology trends, clinical practice updates and supply-chain developments. In addition, a cross-validation process reconciled primary insights with publicly available regulatory documents, clinical guidelines and device labelling to ensure factual consistency. Throughout the methodology, emphasis was placed on triangulation-validating findings across multiple independent sources-and on transparency regarding assumptions and limitations. This approach yields an analytical foundation that balances practical relevance with rigorous scrutiny, enabling confident recommendations for product development, market access, and commercial strategy.

Summative implications and strategic priorities that synthesize clinical, commercial, and operational considerations to guide leadership decisions in resuscitation devices

In conclusion, the resuscitation device domain is at an inflection point where product innovation, digital integration and supply-chain resilience collectively determine competitive outcomes. Advances in device algorithms, connectivity and form factor are making it possible to deliver clinical-grade performance in a wider range of care settings, while tariff and procurement pressures are sharpening the need for cost-effective, flexible manufacturing and distribution strategies. Regional nuances in regulatory expectations and health-system procurement practices require tailored market entry and evidence generation plans to ensure successful commercialization.

Decision-makers should therefore pursue integrated strategies that combine rigorous clinical validation, adaptable supply-chain architectures, and differentiated service offerings to create defensible market positions. Cross-functional alignment between engineering, clinical affairs and commercial teams is essential to translate technical capabilities into valued clinical outcomes and compelling procurement propositions. By focusing on these priorities and by engaging early with key stakeholders, organizations can accelerate adoption, mitigate risk and position themselves for sustained impact in the evolving resuscitation device landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-powered predictive analytics in AEDs for proactive cardiac event detection
  • 5.2. Advancements in portable extracorporeal membrane oxygenation devices for field resuscitation support
  • 5.3. Surge in adoption of battery-free CPR assist devices harnessing kinetic energy for emergency scenarios
  • 5.4. Emergence of cloud-connected defibrillator fleets enabling centralized performance analytics and maintenance alerts
  • 5.5. Integration of real-time telemedicine links in automated resuscitation units to support remote clinical guidance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Resuscitation Devices Market, by Device Type

  • 8.1. Automated External Defibrillators
    • 8.1.1. Fully Automatic
    • 8.1.2. Semi Automatic
  • 8.2. Implantable Cardioverter Defibrillators
    • 8.2.1. Biventricular
    • 8.2.2. Dual Chamber
    • 8.2.3. Single Chamber
  • 8.3. Manual External Defibrillators
    • 8.3.1. Portable
    • 8.3.2. Stationary
  • 8.4. Wearable Cardioverter Defibrillators

9. Resuscitation Devices Market, by Application

  • 9.1. Cardiac Arrest
    • 9.1.1. Cardiac Pacing
    • 9.1.2. Cardioversion
    • 9.1.3. Defibrillation
  • 9.2. Respiratory Failure
    • 9.2.1. Invasive Ventilation
    • 9.2.2. Manual Resuscitation
    • 9.2.3. Non Invasive Ventilation

10. Resuscitation Devices Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Emergency Medical Services
  • 10.3. Homecare
  • 10.4. Hospitals
  • 10.5. Specialty Clinics

11. Resuscitation Devices Market, by Sales Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. Online Sales

12. Resuscitation Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Resuscitation Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Resuscitation Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Koninklijke Philips N.V.
    • 15.3.2. Medtronic plc
    • 15.3.3. ZOLL Medical Corporation
    • 15.3.4. Nihon Kohden Corporation
    • 15.3.5. Dragerwerk AG & Co. KGaA
    • 15.3.6. Ambu A/S
    • 15.3.7. Becton, Dickinson and Company
    • 15.3.8. Teleflex Incorporated
    • 15.3.9. Smiths Group plc
    • 15.3.10. Mindray Medical International Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL RESUSCITATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. RESUSCITATION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. RESUSCITATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. RESUSCITATION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL RESUSCITATION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL RESUSCITATION DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY FULLY AUTOMATIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY BIVENTRICULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC PACING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY CARDIOVERSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DEFIBRILLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY INVASIVE VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY MANUAL RESUSCITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY NON INVASIVE VENTILATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOMECARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE RESUSCITATION DEVICES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY CARDIAC ARREST, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST RESUSCITATION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)

TABLE